Mesothelin: a new target for immunotherapy

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
R HassanIra Pastan

Abstract

Mesothelin is a differentiation antigen present on normal mesothelial cells and overexpressed in several human tumors, including mesothelioma and ovarian and pancreatic adenocarcinoma. The mesothelin gene encodes a precursor protein that is processed to yield the 40-kDa protein, mesothelin, attached to the cell membrane by a glycosylphosphatidyl inositol linkage and a 31-kDa shed fragment named megakaryocyte-potentiating factor. The biological function of mesothelin is not known. Mesothelin is a promising candidate for tumor-specific therapy, given its limited expression in normal tissues and high expression in several cancers. SS1(dsFv)PE38 is a recombinant anti-mesothelin immunotoxin that is undergoing clinical evaluation in patients with mesothelin-expressing tumors. There is evidence that mesothelin is an immunogenic protein and could be exploited as a therapeutic cancer vaccine. A soluble mesothelin variant has been identified and could be a useful tumor marker for malignant mesotheliomas.

References

Jun 19, 1992·International Journal of Cancer. Journal International Du Cancer·K ChangM C Willingham
Mar 1, 1992·The American Journal of Surgical Pathology·K ChangM C Willingham
Feb 1, 1992·International Journal of Cancer. Journal International Du Cancer·K ChangM C Willingham
Oct 20, 1995·Science·V E VelculescuK W Kinzler
Sep 15, 1995·The Journal of Biological Chemistry·T KojimaN Yamaguchi
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·K Chang, I Pastan
Feb 6, 1999·International Journal of Cancer. Journal International Du Cancer·R HassanI Pastan
Jun 29, 1999·Nature Biotechnology·P S Chowdhury, I Pastan
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·N SchollerI Hellström
Mar 25, 2000·Molecular and Cellular Biology·T K Bera, I Pastan
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E M JaffeeC J Yeo
Jan 4, 2003·The Journal of Biological Chemistry·Baldwin C MakRaymond S Yeung
Mar 18, 2003·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Nelson G Ordóñez
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert C Bast
Oct 25, 2003·The American Journal of Surgical Pathology·Nelson G Ordóñez
Nov 25, 2003·Lancet·Bruce W S RobinsonIngegerd Hellstrom
Dec 17, 2003·The Journal of Biological Chemistry·Armin RumpAtsushi Miyajima

❮ Previous
Next ❯

Citations

May 10, 2011·Cancer Chemotherapy and Pharmacology·Jan Nyrop Jakobsen, Jens Benn Sørensen
Oct 9, 2008·Immunologic Research·Angel Varela-RohenaJames L Riley
Jan 2, 2013·Medical Oncology·Rosa FilibertiFabio Spigno
Mar 1, 2008·Environmental Health and Preventive Medicine·Okio Hino, Masahiro Maeda
Jun 14, 2005·Current Opinion in Pharmacology·Paul Polakis
May 17, 2011·Journal of Proteomics·Jung-min LeeElise C Kohn
Oct 4, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yoshiaki MiuraMasato Yamamoto
Nov 28, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tae Heung KangChien-Fu Hung
Jan 30, 2008·Nature Clinical Practice. Oncology·Dean A FennellJan van Meerbeeck
May 21, 2005·Nature Reviews. Cancer·Dan Laheru, Elizabeth M Jaffee
Jun 24, 2006·Nature Reviews. Cancer·Ira PastanRobert J Kreitman
Jan 28, 2006·Cancer Gene Therapy·R G van der MostD J Nelson
Jun 22, 2007·Gene Therapy·C-L ChangC-F Hung
Jul 20, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C DarimontK Macé
May 29, 2007·Oncogene·I Zafir-LavieY Reiter
Oct 14, 2005·The New England Journal of Medicine·Bruce W S Robinson, Richard A Lake
Feb 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Carmine CarpenitoCarl H June
Feb 4, 2011·The Journal of Biological Chemistry·Yunzhao R RenScott E Kern
May 31, 2007·Current Opinion in Pulmonary Medicine·Arnaud Scherpereel, Y C Gary Lee
May 7, 2009·Current Opinion in Pulmonary Medicine·Jenette Creaney, Bruce W S Robinson
Jan 22, 2010·Applied Immunohistochemistry & Molecular Morphology : AIMM·Mahlon D JohnsonHoadong Xu
Jan 29, 2008·The American Journal of Surgical Pathology·Zarir E KaranjawalaRalph H Hruban
Jun 22, 2010·TheScientificWorldJournal·Patrick ChamesDaniel Baty
Aug 8, 2012·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Jichun MaDi Xia
Oct 17, 2006·Pathology International·Masahiro Maeda, Okio Hino
Oct 25, 2006·Annual Review of Medicine·Ira PastanRobert J Kreitman
Nov 28, 2007·Annual Review of Pathology·Anirban Maitra, Ralph H Hruban
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Junko YokokawaKwong Y Tsang
Apr 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julie M WuPedram Argani
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert J KreitmanIra Pastan
May 26, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edmund K MoonSteven M Albelda
May 25, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yirong LiPeng Lee
Aug 5, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xing DuIra Pastan
Dec 8, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dung T LeDaniel A Laheru
Mar 1, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elliot L ServaisPrasad S Adusumilli
Feb 19, 2008·Molecular Cancer Therapeutics·Min LiQizhi Yao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.